Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

recombinant interleukin-18

A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-18 (IL-18). Produced primarily by macrophages, IL-18 induces the production of interferon-gamma (IFN-gamma), and enhances the activity of natural killer (NK) and cytotoxic T lymphocytes (CTL). As a potential immunotherapeutic agent, IL-18 displays antitumor effects in vitro and in animal models.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:IFN-gamma-inducing factor
interferon-gamma-inducing factor
Abbreviation:IL-18
Code name:SB-485232
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search